Revance Therapeutics (RVNC)
(Delayed Data from NSDQ)
$4.29 USD
+0.02 (0.47%)
Updated May 9, 2024 04:00 PM ET
After-Market: $3.99 -0.30 (-6.99%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth D Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/09/2024
Time: AMC |
3/2024 | $-0.66 | 0.00% |
Earnings Summary
For their last quarter, Revance Therapeutics (RVNC) reported earnings of -$0.54 per share, beating the Zacks Consensus Estimate of $-0.66 per share. This reflects a positive earnings surprise of 18.18%. Look out for RVNC's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of -$0.56 per share, reflecting a year-over-year increase of 10.81%.
Earnings History
Price & Consensus
Zacks News for RVNC
Krystal Biotech, Inc. (KRYS) Q1 Earnings and Revenues Miss Estimates
RVNC: What are Zacks experts saying now?
Zacks Private Portfolio Services